https://www.fresenius.com en-us Mon, 19 Jan 2026 16:00:00 +0100 Mon, 19 Jan 2026 16:00:00 +0100 Mon, 19 Jan 2026 16:00:00 +0100 <![CDATA[AI in Healthcare: SAP and Fresenius Accelerate Digital Healthcare Delivery]]> Wed, 14 Jan 2026 21:00:00 +0100 <![CDATA[Fresenius advances scalable cell therapy manufacturing with strategic-development agreement]]> Tue, 23 Dec 2025 22:00:00 +0100 <![CDATA[Sale of Austrian project business and spa operations to PORR approved ]]> Thu, 04 Dec 2025 16:00:00 +0100 <![CDATA[Fresenius strengthens biomanufacturing capabilities through AI collaboration]]> Mon, 01 Dec 2025 16:00:00 +0100 <![CDATA[Fresenius Launches Denosumab Biosimilars in EU ]]> Fri, 14 Nov 2025 22:39:22 +0100 <![CDATA[Katrin Kerner and Christian Wagner to lead Group Communications at Fresenius]]> Fri, 14 Nov 2025 19:37:01 +0100 <![CDATA[Fresenius climbs to 2nd place in governance ranking]]> Wed, 05 Nov 2025 13:45:00 +0100 <![CDATA[Fresenius Q3/25: Disciplined execution drives continued strong performance – guidance raised]]> Fri, 10 Oct 2025 16:54:44 +0200 <![CDATA[Fresenius simplifies sale process of Vamed's Austrian operations]]> Thu, 25 Sep 2025 23:00:00 +0200 <![CDATA[Fresenius receives Vizient® Awards for Supply and Service Excellence in the U.S.]]> Mon, 15 Sep 2025 20:00:00 +0200 <![CDATA[Key parameter for the 2026 DRG inflator for German hospitals set at 5.17%]]> Tue, 09 Sep 2025 03:42:29 +0200 <![CDATA[Fresenius successfully places bonds with a volume of 1 billion euros]]> Mon, 08 Sep 2025 21:00:00 +0200 <![CDATA[Fresenius receives a €400 million EIB loan]]> Mon, 01 Sep 2025 16:00:00 +0200 <![CDATA[Fresenius continues streamlining its operations with the divestment of the Calea homecare business in Canada]]> Tue, 26 Aug 2025 17:00:00 +0200 <![CDATA[Fresenius leads new EASYGEN consortium aimed at decentralizing CAR-T cell therapy and improving hospital workflows]]> Wed, 06 Aug 2025 12:44:00 +0200 <![CDATA[Fresenius Q2/25: Guidance raised - Resilient business continues to deliver consistent performance]]> Tue, 05 Aug 2025 16:00:00 +0200 <![CDATA[Fresenius announces licensing agreement with Polpharma Biologics to commercialize a proposed vedolizumab biosimilar candidate]]> Wed, 23 Jul 2025 17:15:18 +0200 <![CDATA[Fresenius Receives European Commission Approval for Denosumab Biosimilars]]> Tue, 01 Jul 2025 20:00:00 +0200 <![CDATA[Fresenius expands Biopharma Portfolio in the U.S. with Denosumab Biosimilars availability]]> here.]]> Tue, 27 May 2025 17:00:00 +0200 <![CDATA[Anke Schmidt appointed Head of Corporate Communications at Fresenius]]>